Biotest AG

40.80
0.00 (0.00%)
At close: Feb 07, 2025, 11:26 AM
undefined%
Bid n/a
Market Cap 1.38B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 1.73
PE Ratio (ttm) 23.58
Forward PE n/a
Analyst n/a
Ask n/a
Volume 145
Avg. Volume (20D) 79
Open 40.80
Previous Close 40.80
Day's Range 40.80 - 40.80
52-Week Range 40.60 - 43.00
Beta undefined

About BIO.DE

Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers its products in hematology, clinical immunology, and intensive care medicine areas. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy and prophylaxis; and Haemonine for haemophilia B acute therapy and prophyl...

Industry Biotechnology
Sector Healthcare
IPO Date Nov 19, 1998
Employees 2,464
Stock Exchange XETRA
Ticker Symbol BIO.DE
No News article available yet